Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 265

Sort by

Sort Order Select

Journal Articles

STING and transplantation: can targeting this pathway improve outcomes?

Cameron S. Bader, Lei Jin, Robert B. Levy

Blood (2021) 137 (14): 1871–1878.

https://doi.org/10.1182/blood.2020008911

Published: 2021

Journal Articles

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

Moritz Bewarder, MD, Gerhard Held, MD, Lorenz Thurner, MD, Klaus Dieter Preuss, PhD, Gabi Carbon, Birgit Bette, Konstantinos Christofyllakis, MD, Arne Felbel, Dominic Kaddu-Mulindwa, MD, Niels Murawski, MD, Stephan Stilgenbauer, Frank Neumann, PhD

Blood (2019) 134 (Supplement_1): 5616.

https://doi.org/10.1182/blood-2019-126998

Published: 2019

Journal Articles

Recurrent JAK3 Mutations in Post-Transplant Lymphoproliferative Disorder

Alexandra Butzmann, MD, Diwash Jangam, PhD, Jyoti Kumar, MDMS, Kaushik Sridhar, MS, Benjamin A Pinsky, MD PhD, Robert S. Ohgami, MD PhD

Blood (2019) 134 (Supplement_1): 5226.

https://doi.org/10.1182/blood-2019-131146

Published: 2019

Journal Articles

Noninvasive and Wearable Optical Monitoring of Brain Death with Aid of a Protocol at Differentiated Fractions of Oxygen Inspired

Ting Li, PhD, Pan Boan, Master, Yuan Gao, Master, Huang Xiaobo, Jiangbo Pu, PhD, Chong Huang

Blood (2019) 134 (Supplement_1): 5808.

https://doi.org/10.1182/blood-2019-124448

Published: 2019

Journal Articles

Fully Closed, Large-Scale, and Clinical Grade Cell Sorting of Hematopoietic Stem Cell (HSC)-Enriched CD90 + Cells for Transplantation and Gene Therapy

Stefan Radtke, PhD, Margaret Cui, Anai M Perez, Yan-Yi Chan, Stefanie Schmuck, BS, Andrew J Berger, PhD, Thomas Eunson, BSc, Hans-Peter Kiem, MD PhD

Blood (2019) 134 (Supplement_1): 3246.

https://doi.org/10.1182/blood-2019-125969

Published: 2019

Journal Articles

Multiple Pathways Targeting CD25 or TNFRSF25 Affect CD4 + FoxP3 + Regulatory T Cell Phenotype and Suppressive Function

Sabrina N. Copsel, PhD, Henry Barreras, MPH, Casey O. Lightbourn, BS, MS, Cameron S. Bader, BS, Dietlinde Wolf, PhD, Brandon Kale, Warren Alperstein, MD, Krishna V Komanduri, MD, Robert B. Levy, PhD

Blood (2019) 134 (Supplement_1): 4430.

https://doi.org/10.1182/blood-2019-130649

Published: 2019

Journal Articles

Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor

Shoko Oshima, MD, Akihito Shinohara, MD, Hideki Ishida, MD PhD, Miki Umeda, MD, Satoko Osanai, MD, Satoru Itoi, MD, Michiko Ryuzaki, MD, Yuki Izuka, MD, Aya Watanabe, MD, Norina Tanaka, MD PhD, Midori Ishiyama, MD PhD, Hiroshi Kazama, MD PhD, Kentaro Yoshinaga, MD PhD, Shotaro Hagiwara, MD PhD, Masayuki Shiseki, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 2910.

https://doi.org/10.1182/blood-2019-125601

Published: 2019

Journal Articles

CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria

Blood (2019) 134 (Supplement_1): 2887.

https://doi.org/10.1182/blood-2019-129532

Published: 2019

Journal Articles

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

Fang Liu, MD PhD, Hongyu Zhang, MD PhD, Xiao Wang, MD PhD, Yisong Xiong, PhD, Yuanzhen Cao, Yi Su, MD, Hai Yi, MD PhD, Jia Feng, MD PhD, Wenli Zhang, MD, Yu Ma, Masayuki Wada, PhD, Yupo Ma, MD PhD

Blood (2019) 134 (Supplement_1): 38.

https://doi.org/10.1182/blood-2019-122964

Published: 2019

Journal Articles

Solid Organ Transplant Rejection Associated with the Use of the Immunomodulatory Drugs (IMIDs)

Michelle Nadeau Nguyen, Afrouz Nayernama, PharmD, Steven Christopher Jones, PharmD, Yvette L. Kasamon, MD, Peter E. Waldron, MD

Blood (2019) 134 (Supplement_1): 2189.

https://doi.org/10.1182/blood-2019-123146

Published: 2019

Journal Articles

Impact of ABO Blood Group Incompatibility on Outcomes after Single-Unit Umbilical Cord Blood Transplantation for Malignant Hematological Disease

Cheng Siqi, Baolin Tang, Xiaoyu Zhu, Huilan Liu, Kaidi Song, Xiang Wan, Wen Yao, Jian Wang, Zimin Sun

Blood (2019) 134 (Supplement_1): 2055.

https://doi.org/10.1182/blood-2019-130699

Published: 2019

Journal Articles

Psychological and Social Factors Are a Strong Predictor of Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Independent of Disease Risk and Morbidity Score

Melhem Solh, MD, Dawn Speckhart, PhD, Xu Zhang, PhD, Asad Bashey, MD PhD, Scott R. Solomon, MD, Lawrence E Morris, MD, H. Kent Holland, MD

Blood (2019) 134 (Supplement_1): 3493.

https://doi.org/10.1182/blood-2019-131639

Published: 2019

Journal Articles

Interleukin-15 (IL-5) in Combination with Avelumab in Relapsed/Refractory Mature T-Cell Malignancies

Milos D. Miljkovic, MDMSc, Kevin C Conlon, MD, Sigrid Dubois, PhD, Jennifer Hsu, RN, Jeffrey Schlom, PhD, James Gulley, MD PhD, Thomas A. Waldmann, MD

Blood (2019) 134 (Supplement_1): 1558.

https://doi.org/10.1182/blood-2019-128945

Published: 2019

Journal Articles

Epidemiology of Post-Transplant Lymphoproliferative Disorders in Children with Solid Organ Transplant over 34 Years of a Single Center Experience

Marta Rojas Vasquez, MD FRCPC, Anthea Peters, MSc, MD FRCPC, Raymond Lai, MD PhD FRCP, Curtis Mabilangan, MSc, Burton Catherine, MD FRCPC, Jutta Preiksaitis, MDFRCPC

Blood (2019) 134 (Supplement_1): 1602.

https://doi.org/10.1182/blood-2019-125344

Published: 2019

Journal Articles

Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor?

Camillo Almici, MD, Francesca Fontana, Giovanna Piovani, Piera Balzarini, Arabella Neva, Benedetto Bruno, MD, Cristina Skert, GianLuca Rotta, Simona Fisogni, MD, Rosanna Verardi, Andrea Bianchetti, Simona Braga, Michele Malagola, MD, Nicolò Manaresi, PhD, Fabio Facchetti, Mirella Marini, MD, Domenico Russo, MD

Blood (2019) 134 (Supplement_1): 4885.

https://doi.org/10.1182/blood-2019-121879

Published: 2019

Journal Articles

Causes of Death in 198 Sickle Cell Adult Patients: Old and New Trends

Anoosha Habibi, Stephanie Ngo, MD, Etienne Audureau, MD PhD, Armand Mekontso-Dessap, MD PhD, Keyvan Razazi, MD, Elena Foïs, MD, Thibaud Damy, MD PhD, France Pirenne, MD PhD, Marc Michel, Vincent Audard, MD PhD, Frédéric Galactéros, MD PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1031.

https://doi.org/10.1182/blood-2019-131304

Published: 2019

Journal Articles

Risk of Post-Transplant Lymphoproliferative Disorders (PTLD) in Solid Organ Transplantation Patients with EBV Viremia

Yazeed Sawalha, MD, John McMichael, PhD, Lisa Rybicki, MS, Tamara A. Sussman, MD, Alex V. Mejia Garcia, MD, Robert M. Dean, MD, Brad Pohlman, MD, Brian T. Hill, MD PhD, Deepa Jagadeesh, MD MPH

Blood (2018) 132 (Supplement 1): 4202.

https://doi.org/10.1182/blood-2018-99-114686

Published: 2018

Journal Articles

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Thomas M. Habermann, MD, Angelo Fama, MD, Kay M. Ristow, BS, Matthew J. Maurer, MS, William R. Macon, MD, Stephen M. Ansell, MD PhD, Nabila Nora Bennani, MD, Yogish C Kudva, MBBS, Randall C. Walker, MD, Kimberly D. Watt, Thomas R. Schwab, MD, James R. Cerhan, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 456.

https://doi.org/10.1182/blood-2018-99-113667

Published: 2018

Journal Articles

Autoimmune Cytopenias Following Alemtuzumab-Induced Renal Transplant: Clinical Features and Treatment Outcomes

Elisa Lucchini, MD, Asad Luqmani, MD, Maria Atta, MD, Simona Deplano, MD PhD, Mark Layton, MB, FRCP, Camelia Vladescu, Deena Paul, Andreas Kousios, MD, Rawya Charif, MD, Nichola Cooper, MRCP

Blood (2018) 132 (Supplement 1): 2434.

https://doi.org/10.1182/blood-2018-99-115258

Published: 2018

Journal Articles

BZLF1-DEC205 Fusion Protein Enhances EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

Elshafa Hassan Ahmed, DVM, Eric Brooks, Shelby Sloan, BS, Sarah Schlotter, Frankie Jeney, Charlene Mao, Polina Shindiapina, MD PhD, Salma Shire, Claire Hale, Manjusri Das, Alexander Prouty, Michael A. Caligiuri, MD, Robert A Baiocchi, MD PhD

Blood (2018) 132 (Supplement 1): 342.

https://doi.org/10.1182/blood-2018-99-117837

Published: 2018

NARROW

STING and transplantation: can targeting this pathway improve outcomes?

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

Recurrent JAK3 Mutations in Post-Transplant Lymphoproliferative Disorder

Noninvasive and Wearable Optical Monitoring of Brain Death with Aid of a Protocol at Differentiated Fractions of Oxygen Inspired

Fully Closed, Large-Scale, and Clinical Grade Cell Sorting of Hematopoietic Stem Cell (HSC)-Enriched CD90 + Cells for Transplantation and Gene Therapy

Multiple Pathways Targeting CD25 or TNFRSF25 Affect CD4 + FoxP3 + Regulatory T Cell Phenotype and Suppressive Function

Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor

CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

Solid Organ Transplant Rejection Associated with the Use of the Immunomodulatory Drugs (IMIDs)

Impact of ABO Blood Group Incompatibility on Outcomes after Single-Unit Umbilical Cord Blood Transplantation for Malignant Hematological Disease

Psychological and Social Factors Are a Strong Predictor of Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Independent of Disease Risk and Morbidity Score

Interleukin-15 (IL-5) in Combination with Avelumab in Relapsed/Refractory Mature T-Cell Malignancies

Epidemiology of Post-Transplant Lymphoproliferative Disorders in Children with Solid Organ Transplant over 34 Years of a Single Center Experience

Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor?

Causes of Death in 198 Sickle Cell Adult Patients: Old and New Trends

Risk of Post-Transplant Lymphoproliferative Disorders (PTLD) in Solid Organ Transplantation Patients with EBV Viremia

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Autoimmune Cytopenias Following Alemtuzumab-Induced Renal Transplant: Clinical Features and Treatment Outcomes

BZLF1-DEC205 Fusion Protein Enhances EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only